{"DataElement":{"publicId":"6779720","version":"1","preferredName":"International Prognostic Index Risk Assessment Category","preferredDefinition":"Text term that represents the risk group description of how an individual with non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.","longName":"IPI_RISK_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6776845","version":"1","preferredName":"International Prognostic Index Risk Assessment","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))_The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._The final result of a determination of the value, significance, or extent of.","longName":"6776842v1.0:6776843v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6776842","version":"1","preferredName":"International Prognostic Index","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","longName":"C20118","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Index","conceptCode":"C20118","definition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6516-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6776843","version":"1","preferredName":"Risk Assessment","preferredDefinition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:The final result of a determination of the value, significance, or extent of.","longName":"C17102:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6527-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCF464-6538-4C11-E053-F662850AFFDE","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":"Created for NCI-INC0386214-CDE Import - IPI Score request by Pam. 6.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6779709","version":"1","preferredName":"IPI Category","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))_A grouping of items based on some commonality or by user defined characteristics.","longName":"IPI_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High risk","valueDescription":"IPI High Risk Group","ValueMeaning":{"publicId":"6779710","version":"1","preferredName":"IPI High Risk Group","longName":"6779710","preferredDefinition":"A risk group associated with a total score of 4 or 5 on the International Prognostic Index indicating that an individual has a 5 year survival prognosis of 32%.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-72C5-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B121B28-72DE-7AC5-E053-F662850A0DA3","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"High-intermediate risk","valueDescription":"IPI High-intermediate Risk Group","ValueMeaning":{"publicId":"6779711","version":"1","preferredName":"IPI High-intermediate Risk Group","longName":"6779711","preferredDefinition":"A risk group associated with a total score of 3 on the International Prognostic Index indicating that an individual has a 5 year survival prognosis of 46%.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-72E8-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B121B28-7301-7AC5-E053-F662850A0DA3","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"Low-intermediate risk","valueDescription":"IPI Low-intermediate Risk Group","ValueMeaning":{"publicId":"6779712","version":"1","preferredName":"IPI Low-intermediate Risk Group","longName":"6779712","preferredDefinition":"A risk group associated with a total score of 2 on the International Prognostic Index indicating that an individual has a 5 year survival prognosis of 69%.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-730B-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B121B28-7324-7AC5-E053-F662850A0DA3","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"Low risk","valueDescription":"IPI Low Risk Group","ValueMeaning":{"publicId":"6779713","version":"1","preferredName":"IPI Low Risk Group","longName":"6779713","preferredDefinition":"A risk group associated with a total score of 0 or 1 on the International Prognostic Index indicating that an individual has a 5 year survival prognosis of 73%.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-732E-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B121B28-7347-7AC5-E053-F662850A0DA3","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6779708","version":"1","preferredName":"International Prognostic Index Category","preferredDefinition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org)):A grouping of items based on some commonality or by user defined characteristics.","longName":"C20118:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Index","conceptCode":"C20118","definition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-72A0-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-72B1-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"International Prognostic Inde","type":"Preferred Question Text","description":"International Prognostic Index (IPI) Risk Category","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-7353-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}